Rozlytrek from Roche gets EC approval to treat solid tumours and NSCLC
The approval is based on results from the integrated analysis of the pivotal phase II STARTRK-2, phase I STARTRK-1 and phase I…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.